Pyxis Oncology, Inc. (PYXS) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-02

Pyxis Oncology, Inc. (PYXS) has filed 1 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 4 Form 8-K material event filings were reported by PYXS in the last 90 days. 1 Form 144 notices of proposed sale were filed for PYXS stock. InsiderAlpha tracks every PYXS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Pyxis Oncology, Inc. (PYXS)

SEC CIK	0001782223

90-Day SEC Filing Activity

Form 4 filings (90d)	1
Form 8-K filings (90d)	4
Form 144 notices (90d)	1
Latest Form 4 filing	2026-07-02

Recent PYXS Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-06-30	Dupont Jakob	Insider	M — Option exercise	35.0K	$1.60	$56K	SEC
2026-06-30	Dupont Jakob	Insider	S — Open-market sale	35.0K	$3.06	$107K	SEC
2026-03-24	Wadhane Jitendra	Prin Fin & Acct Officer	A — Grant or award	109.5K	$0.00	—	SEC
2024-11-26	Connealy Pamela Ann	CFO & COO	P — Open-market purchase	5.5K	$2.00	$11K	SEC
2024-11-26	Connealy Pamela Ann	CFO & COO	P — Open-market purchase	83.4K	$1.96	$163K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Pyxis Oncology, Inc. (PYXS). Updated in real time as new filings are submitted to the SEC.

Most-Active PYXS Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Dupont Jakob	3	$163K

Recent PYXS Form 8-K Material Events

2026-07-02 — Item 1.01, 3.02, 7.01 [SEC]
2026-06-15 — Item 5.07 [SEC]
2026-05-14 — Item 2.02 [SEC]
2026-04-30 — Item 5.02 [SEC]
2026-03-23 — Item 2.02, 7.01 · Earnings · neutral [SEC]
Pyxis Oncology announced its full-year 2025 financial results and provided a corporate update on March 23, 2026. The filing includes a press release and updated corporate presentation but does not disclose specific financial metrics or performance details in the 8-K excerpt provi

Recent PYXS Form 144 Notices of Proposed Sale

2026-06-30 — — [SEC]

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

2026-07-02 — Dupont Jakob (Insider)
2026-03-25 — Dupont Jakob (Insider)
2026-03-25 — Wadhane Jitendra (Prin Fin & Acct Officer)
2026-03-25 — FLAVIN JOHN L (Insider)
2026-03-25 — Metzger Michael A (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PYXS insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

PYXS Insider Trading — FAQ

What is the latest insider trade for PYXS?: Pyxis Oncology, Inc. (PYXS) had 1 insider filings in the last 90 days, with the most recent on 2026-07-02. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying PYXS stock?: 0 insider purchases of PYXS were filed in the last 90 days.
How many insiders are selling PYXS stock?: 0 insider sales of PYXS were filed in the last 90 days.
Where can I see PYXS SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every PYXS SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live PYXS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.